AI assistant
Sending…
LEMAITRE VASCULAR INC — Director's Dealing 2015
Jul 27, 2015
31708_dirs_2015-07-27_79f3e363-68a9-4bc8-af18-41a76d6323c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: LEMAITRE VASCULAR INC (LMAT)
CIK: 0001158895
Period of Report: 2015-07-23
Reporting Person: Gebauer Peter R (President, International OP)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-07-27 | Common Stock | M | 5513 | $5.85 | Acquired | 70420 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-07-23 | Stock Option (Right to Buy) | $11.43 | A | 29239 | Acquired | 2022-07-23 | Common Stock (29239) | Direct |
| 2015-07-27 | Stock Option (Right to Buy) | $5.85 | M | 5513 | Disposed | 2017-07-26 | Common Stock (5513) | Direct |
Footnotes
F1: Represents shares acquired upon exercise of options by the Reporting Person, as reported in Table II.
F2: This option is exercisable and vests over a five-year period at a rate of 20% on the first anniversary of the date listed in the table, and the balance vesting in equal annual installments over the remaining four years.
F3: This option is fully vested and exercisable.
More from LEMAITRE VASCULAR INC
Regulatory Filings
2026
May 29
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 5
Proxy Solicitation & Information Statement
2026
Apr 14
Board/Management Information
2026
Apr 14
Annual Report
2026
Apr 14
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3